1)Kim H, et al : A guide to genome engineering with programmable nucleases. Nat Rev Genet 15 : 321─334, 2014
2)Jabalameli HR, et al : Zinc finger nuclease technology : advances and obstacles in modelling and treating genetic disorders. Gene 558 : 1─5, 2015
3)Joung JK, et al : TALENs : a widely applicable technology for targeted genome editing. Nat Rev Mol Cell Biol 14 : 49─55, 2013
4)Doudna JA, et al : Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346 : 1258096, 2014
5)Naldini L : Gene therapy returns to centre stage. Nature 526 : 351─360, 2015
6)Tebas P, et al : Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl J Med 370 : 901─910, 2014
7)Li H, et al : In vivo genome editing restores haemostasis in a mouse model of haemophilia. Nature 475 : 217─221, 2011
8)Sharma R, et al : In vivo genome editing of the albumin locus as a platform for protein replacement therapy. Blood 126 : 1777─1784, 2015
9)Maude SL, et al : Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med 371 : 1507─1517, 2014
10)Qasim W, et al : First clinical application of Talen engineered universal CAR19 T cells in B-ALL(ASH annual meeting abstract). Blood 126 : 2046, 2015
11)Reardon S : Leukaemia success heralds wave of gene-editing therapies. Nature 527 : 146─147, 2015
12)Second baby gets Cellectis “designer” cells to clear leukaemia. REUTERS Health News, May 6, 2016, http://www.reuters.com/article/us-health-celltherapy-idUSKCN0XX1F7
13)Qasim W, et al : Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells. Sci Transl Med 9 eaaj 2013, 2017
14)Cyranoski D : Chinese scientists to pioneer first human CRISPR trial. Nature 535 : 476─477, 2016
15)Lombardo A, et al : Genome editing : a tool for research and therapy : targeted genome editing hits the clinic. Nat Med 20 : 1101─1103, 2014